<DOC>
	<DOC>NCT01173965</DOC>
	<brief_summary>Endometrial ablation in women with dysfunctional uterine bleeding using second generation ablation devices is a common widespread therapeutic approach. This study aims to prove that amenorrhoea rates using Novasure are higher than those observed in microwave endometrial ablation, one year following intervention.</brief_summary>
	<brief_title>Endometrial Ablation With Non-hysteroscopic Methods</brief_title>
	<detailed_description />
	<mesh_term>Hemorrhage</mesh_term>
	<mesh_term>Uterine Hemorrhage</mesh_term>
	<mesh_term>Metrorrhagia</mesh_term>
	<criteria>Women presenting with dysfunctional uterine bleeding having completed their family planning(no wish for further childbearing) Endometrial pathology FSH &gt; 20 day 2 day 3 of the cycle Clotting Disorders Thyroid Dysfunction</criteria>
	<gender>Female</gender>
	<minimum_age>30 Years</minimum_age>
	<maximum_age>49 Years</maximum_age>
	<verification_date>September 2009</verification_date>
</DOC>